Cargando…

Health-care Resource Requirements and Potential Financial Consequences of an Environmentally Driven Switch in Respiratory Inhaler Use in England

Background: To reduce greenhouse gas emissions, national initiatives advocate the phasing down of respiratory inhalers that use a fluorinated gas as a propellant (pressurised metered-dose inhalers [pMDI]). Nevertheless, pMDIs continue to be an effective and common choice. Objective: To assess the po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Attar-Zadeh, Darsuh, Lewis, Harriet, Orlovic, Martina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Columbia Data Analytics, LLC 2021
Materias:	Respiratory Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460426/ https://www.ncbi.nlm.nih.gov/pubmed/34616856 http://dx.doi.org/10.36469/001c.26113

Ejemplares similares

Costs of switching to low global warming potential inhalers. An economic and carbon footprint analysis of NHS prescription data in England
por: Wilkinson, Alexander J K, et al.
Publicado: (2019)

PROMETHEUS: Long-Term Exacerbation and Mortality Benefits of Implementing Single-Inhaler Triple Therapy in the US COPD Population
por: Criner, Gerard, et al.
Publicado: (2023)

Clinical and financial burden of hospitalised community-acquired pneumonia in patients with selected underlying comorbidities in England
por: Campling, James, et al.
Publicado: (2020)

Applied Comparison of Meta-analysis Techniques
por: Wang, Li, et al.
Publicado: (2013)

Mother’s education and offspring asthma risk in 10 European cohort studies
por: Lewis, Kate Marie, et al.
Publicado: (2017)

Impact of changes to reimbursement of fixed combinations of inhaled corticosteroids and long-acting β(2)-agonists in obstructive lung diseases: a population-based, observational study
por: Björnsdóttir, U S, et al.
Publicado: (2014)

Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam Study
por: Terzikhan, Natalie, et al.
Publicado: (2016)

Patient-Centric Structural Determinants of Adherence Rates Among Asthma Populations: Exploring the Potential of Patient Activation and Encouragement Tool TRUSTR to Improve Adherence
por: Zia, Asim, et al.
Publicado: (2020)

The Burden of Hypoxic Respiratory Failure in Preterm and Term/Near-term Infants in the United States 2011-2015
por: Pandya, Shivani, et al.
Publicado: (2019)

Cost Impact Model of a Novel Multi-mRNA Host Response Assay for Diagnosis and Risk Assessment of Acute Respiratory Tract Infections and Sepsis in the Emergency Department
por: Schneider, John E., et al.
Publicado: (2020)

Early life exposures and risk of adult respiratory disease during 50 years of follow-up
por: Johansson, Carl J., et al.
Publicado: (2020)

Economic Evaluation of FebriDx®: A Novel Rapid, Point-of-Care Test for Differentiation of Viral versus Bacterial Acute Respiratory Infection in the United States
por: Dick, Katherine, et al.
Publicado: (2021)

The Burden of Cost in Bronchiolitis Obliterans Syndrome: Predictions for the Next Decade
por: Jones, Christopher A., et al.
Publicado: (2016)

Generalized Propensity Score Matching with Multilevel Treatment Options
por: Baser, Onur
Publicado: (2013)

Montelukast Use and Patterns of Ambulatory Care among Asian versus Non-Asian Adult Patients with Asthma and/or Allergic Rhinitis in the United States
por: Vasey, Joseph, et al.
Publicado: (2015)

Economic Impact of Changes in Neonatal Intensive Care Unit Ventilation Strategies with the Advent of New Noninvasive Ventilation Techniques: A Review and Proposed Assessment Framework for High Flow Therapy as a Routine Respiratory Support Paradigm
por: Pietzsch, Jan B., et al.
Publicado: (2015)

A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting β(2)-agonists for asthma maintenance treatment in Germany
por: Aballéa, S, et al.
Publicado: (2008)

Inhaled therapies for chronic obstructive pulmonary disease: a systematic review and meta-analysis
por: Axson, Eleanor L, et al.
Publicado: (2020)

5‐HT7 receptors expressed in the mouse parafacial region are not required for respiratory chemosensitivity
por: Shi, Yingtang, et al.
Publicado: (2022)

Protocol for a systematic literature review and network meta-analysis of the clinical benefit of inhaled maintenance therapies in chronic obstructive pulmonary disease
por: Lewis, Adam, et al.
Publicado: (2019)

Rat model of smoke inhalation-induced acute lung injury
por: Leiphrakpam, Premila Devi, et al.
Publicado: (2021)

Evaluation of inhaler handling-errors, inhaler perception and preference with Spiromax, Easyhaler and Turbuhaler devices among healthy Finnish volunteers: a single site, single visit crossover study (Finhaler)
por: Sandler, Niklas, et al.
Publicado: (2016)

Patient financial incentives to improve asthma management: a systematic review
por: Hine, Jasmine, et al.
Publicado: (2023)

Chemical exposure and alveolar macrophages responses: ‘the role of pulmonary defense mechanism in inhalation injuries’
por: Tapak, Mahtab, et al.
Publicado: (2023)

Physiotherapy assessment of breathing pattern disorder: a qualitative evaluation
por: Grillo, Lizzie, et al.
Publicado: (2023)

A randomised controlled trial of small particle inhaled steroids in refractory eosinophilic asthma (SPIRA)
por: Hodgson, David, et al.
Publicado: (2015)

Do statins improve outcomes in patients with asthma on inhaled corticosteroid therapy? A retrospective cohort analysis
por: Lokhandwala, Tasneem, et al.
Publicado: (2012)

Validation of a metered dose inhaler electronic monitoring device: implications for asthma clinical trial use
por: Pilcher, Janine, et al.
Publicado: (2016)

Identification of responders to inhaled corticosteroids in a chronic obstructive pulmonary disease population using cluster analysis
por: Hinds, David R, et al.
Publicado: (2016)

Environmental impact of inhalers for respiratory diseases: decreasing the carbon footprint while preserving patient-tailored treatment
por: Panigone, Sara, et al.
Publicado: (2020)

Impact of smoking status on the efficacy of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review
por: Sonnex, Kimberley, et al.
Publicado: (2020)

Stratified assessment of the role of inhaled hypertonic saline in reducing cystic fibrosis pulmonary exacerbations: a retrospective analysis
por: Dmello, Dayton, et al.
Publicado: (2011)

THE EFFECTS OF THE ANTECEDENT USE OF INHALED STEROID ON THE CLINICAL COURSE OF COVID-19: A RETROSPECTIVE STUDY OF PATIENTS WITH ASTHMA
por: ALHARBI, E., et al.
Publicado: (2022)

Which patients with chronic obstructive pulmonary disease benefit from the addition of an inhaled corticosteroid to their bronchodilator? A cluster analysis
por: DiSantostefano, Rachael L, et al.
Publicado: (2013)

Investigation of potential substandard dry powder inhalers on EU and North African markets – evaluation of the delivered and fine particle doses
por: Zhang, Yue, et al.
Publicado: (2022)

‘The blue one takes a battering’ why do young adults with asthma overuse bronchodilator inhalers? A qualitative study
por: Cole, Sue, et al.
Publicado: (2013)

Electronic reminders and rewards to improve adherence to inhaled asthma treatment in adolescents: a non-randomised feasibility study in tertiary care
por: De Simoni, Anna, et al.
Publicado: (2021)

Determinants of poor inhaler technique and poor therapy adherence in obstructive lung diseases: a cross-sectional study in community pharmacies
por: Vanoverschelde, Anna, et al.
Publicado: (2021)

Impact of social deprivation on clinical outcomes of adults hospitalised with community-acquired pneumonia in England: a retrospective cohort study
por: Lawrence, Hannah, et al.
Publicado: (2022)

Safety and efficacy of tiotropium in patients switching from HandiHaler to Respimat in the TIOSPIR trial
por: Dahl, Ronald, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jplml3gg1gb5rdfssmgj27f436